AKTS as of Nov 2 · 18:21 ET
AKTSNasdaqPharmaceutical Preparations
Aktis Oncology, Inc. · Brief
Next report
No upcoming report date.
Expected move
No implied move.
—≥ implied
Q1 FY26—▲+8.16%—
May 11 '26—▲+7.99%—
Q2 FY26±17.0%▲+4.79%×0.28
quarterimplied−20%0+20%realized×
Q2 FY26±17.0%▲+4.79%×0.28
May '26—▲+7.99%—
Q1 FY26—▲+8.16%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Bull2
Bear2 of 4
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
AKTS report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.